Barely Significant
← all excerpts

Safety of Antihypertensive Medications in Pregnancy: Living With Uncertainty.

J Am Heart Assoc · 2019 · PMC6761622 · PMID 31345085

1
hedged sentence
closest p
boldest claim

The sentences

may not be significantno p-value reported
18 However, if the extended‐release preparation of nifedipine is used, the differences may not be significant in terms of 24‐hour BP control or side effects. 19 The slow onset of amlodipine also implies that antihypertensive effects are delayed (≈8 hours). 16 Limited information suggests that both nifedipine and amlodipine get into breast milk but are unlikely to be associated with adverse fetal effects. 20 Additional questions, not addressed by most studies, assess the impact of drug safety for different maternal diagnoses (eg, preeclampsia versus chronic hypertension) and pregnancy‐related changes in drug pharmacokinetics.

also in 2,774 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.